ACAMBIS TO RECEIVE $19M IN SETTLEMENT OVER ARILVAX

Acambis plc announces that Novartis AG has agreed to pay Acambis $19m in cash to settle a dispute related to the ARILVAXTM yellow fever vaccine. Acambis (http://www.acambis.com/default.asp?id=1674)